Vitamin D-3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats

被引:37
作者
Yamamoto, N
Naraparaju, VR
机构
[1] Lab. of Cancer Immunol. and M., Albert Einstein Cancer Center, Korman Research Pavilion, Philadelphia, PA 19141
[2] Lab. of Cancer Immunol. and M., Albert Einstein Cancer Center, Philadelphia
关键词
D O I
10.1006/cimm.1996.0148
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
When rat peritoneal nonadherent cells were treated with inflammatory lipid metabolites and cultured with adherent cells in 1% fetal calf serum (FCS) supplemented medium RPMI 1640 (FCS medium) for 3 hr, markedly enhanced phagocytic and superoxide generating capacities of macrophages were observed. Stepwise preparation of conditioned medium of lysophosphatidylcholine (lyso-Pc)-treated B cells and untreated T cells in FCS medium generated a potent macrophage activating factor whereas cultivation of lyse-Pc-treated B cells alone in a 1% adult rat serum supplemented medium efficiently generated the macrophage activating factor. Generation of macrophage activating factor requires a precursor protein, serum vitamin D-3-binding protein (DBP), as well as participation of lymphocyte glycosidases. The lyse-Pc-inducible beta-galactosidase of B lymphocytes and the Neu-1 sialidase of T lymphocytes modified bovine DBP (bDBP) to yield the macrophage activating factor, a protein with N-acetylgalactosamine as the remaining sugar, In contrast, lyso-Pc-inducible beta-galactosidase of B cells alone modified rat DBP (rDBP) to yield the macrophage activating factor, a protein with N-acetylgalactosamine as the remaining sugar, Thus, we conclude that bDBP carries a trisaccharide composed of N-acetylgalactosamine, galactose, and sialic acid while rDBP carries a disaccharide composed of N-acetylgalactosamine and galactose. (C) 1996 Academic Press, Inc.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 30 条
[1]  
BABIOR BM, 1981, METHODS HEMATOLOGY L, P1
[2]   STUDIES OF MACROPHAGE COMPLEMENT RECEPTOR - ALTERATION OF RECEPTOR FUNCTION UPON MACROPHAGE ACTIVATION [J].
BIANCO, C ;
GRIFFIN, FM ;
SILVERSTEIN, SC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (06) :1278-1290
[3]   DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES - MORPHOLOGY CYTOCHEMISTRY AND BIOCHEMISTRY [J].
COHN, ZA ;
BENSON, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 121 (01) :153-&
[4]  
COOKE NE, 1986, J BIOL CHEM, V261, P3441
[5]   VITAMIN-D BINDING-PROTEIN (GC-GLOBULIN) [J].
COOKE, NE ;
HADDAD, JG .
ENDOCRINE REVIEWS, 1989, 10 (03) :294-307
[6]   SPECIFIC DEGRANULATION OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
ESTENSEN, RD ;
WHITE, JG ;
HOLMES, B .
NATURE, 1974, 248 (5446) :347-348
[7]  
GILL TJ, 1982, J IMMUNOGENET, V9, P281
[8]  
HOMMA S, 1990, CLIN EXP IMMUNOL, V79, P307
[9]   A SERUM FACTOR FOR MACROPHAGE ACTIVATION AFTER INVITRO DODECYLGLYCEROL TREATMENT OF MOUSE LYMPHOCYTES [J].
HOMMA, S ;
MILLMAN, I ;
YAMAMOTO, N .
IMMUNOLOGY AND CELL BIOLOGY, 1990, 68 :137-142
[10]   VITAMIN-D-BINDING PROTEIN (GROUP-SPECIFIC COMPONENT) IS THE SOLE SERUM-PROTEIN REQUIRED FOR MACROPHAGE ACTIVATION AFTER TREATMENT OF PERITONEAL-CELLS WITH LYSOPHOSPHATIDYLCHOLINE [J].
HOMMA, S ;
YAMAMOTO, M ;
YAMAMOTO, N .
IMMUNOLOGY AND CELL BIOLOGY, 1993, 71 :249-257